Disruptive Technology Advisers LLC 23and Me Holding Co. Transaction History

Disruptive Technology Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.19 - $3.98 $413,934 - $752,263	-189,011 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$3.28 - $7.12 $4.04 Million - $8.77 Million	-1,231,932 Reduced 86.7%	189,011 $724,000
Q4 2021 Feb 02, 2022	SELL	$6.55 - $13.25 $14.6 Million - $29.5 Million	-2,228,351 Reduced 61.06%	1,420,943 $9.46 Million
Q2 2021 Aug 11, 2021	BUY	$9.87 - $13.32 $36 Million - $48.6 Million	3,649,294 New	3,649,294 $42.7 Million

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Disruptive Technology Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Disruptive Technology Advisers LLC with notifications on news.